Beschreibung
InhaltsangabeContents List of principal contributors List of chairpersons Preface SECTION I: METABOLIC AND TOXIC HEPATITIS.- 1 NASH: bench to bedside -- lessons from animal models.- 2 Alcohol-induced hepatitis: pathophysiology and treatment.- 3 Drug-induced hepatitis.- SECTION II: CHOLESTATIC HEPATITIS 4 Liver disease in pregnancy: diagnosis and treatment.- 5 Geoepidemiology of primary biliary cirrhosis.-6 Interface hepatitis in primary biliary cirrhosis: prognostic marker and therapeutic target.- SECTION III: VIRAL HEPATITIS (PART 1).- 7 Pathobiology of hepatitis B virus infection.- 8 Individualized treatment of hepatitis C.- SECTION IV: VIRAL HEPATITIS (PART 2).- 9 The future in the treatment of hepatitis C.- 10 Treatment of interferon non-responder patients with chronic hepatitis C in Asia.- SECTION V: AUTOIMMUNE HEPATITIS.- 11 Update on autoimmune hepatitis.- 12 Overlap syndromes Laudatio on the occasion of Professor Gerok's 80th birthday.- 13 Wolfgang Gerok State-of-the-Art Lecture: Pathogenesis of hepatic encephalopathy.- SECTION VI: SEQUELAE OF CHRONIC HEPATITIS (PART 1) Presentation of the International Dame Sheila Sherlock Award.- 14 Award Lecture: Past, present and future of hepatology.- 15 Progression of chronic hepatitis: from inflammation to fibrosis.- 16 Treatment of portal hypertension and variceal bleeding.- 17 Management of ascites and spontaneous bacterial peritonitis.- SECTION VII: SEQUELAE OF CHRONIC HEPATITIS (PART 2).- 18 Advances in the pathogenesis and treatment of type 1 and type 2 hepatorenal syndrome.- 19 Hepatopulmonary syndrome.- 20 Hepatocellular carcinoma Index
Autorenportrait
InhaltsangabeContents List of principal contributors List of chairpersons Preface SECTION I: METABOLIC AND TOXIC HEPATITIS.- 1 NASH: bench to bedside -- lessons from animal models.- 2 Alcohol-induced hepatitis: pathophysiology and treatment.- 3 Drug-induced hepatitis.- SECTION II: CHOLESTATIC HEPATITIS 4 Liver disease in pregnancy: diagnosis and treatment.- 5 Geoepidemiology of primary biliary cirrhosis.-6 Interface hepatitis in primary biliary cirrhosis: prognostic marker and therapeutic target.- SECTION III: VIRAL HEPATITIS (PART 1).- 7 Pathobiology of hepatitis B virus infection.- 8 Individualized treatment of hepatitis C.- SECTION IV: VIRAL HEPATITIS (PART 2).- 9 The future in the treatment of hepatitis C.- 10 Treatment of interferon non-responder patients with chronic hepatitis C in Asia.- SECTION V: AUTOIMMUNE HEPATITIS.- 11 Update on autoimmune hepatitis.- 12 Overlap syndromes Laudatio on the occasion of Professor Gerok's 80th birthday.- 13 Wolfgang Gerok State-of-the-Art Lecture: Pathogenesis of hepatic encephalopathy.- SECTION VI: SEQUELAE OF CHRONIC HEPATITIS (PART 1) Presentation of the International Dame Sheila Sherlock Award.- 14 Award Lecture: Past, present and future of hepatology.- 15 Progression of chronic hepatitis: from inflammation to fibrosis.- 16 Treatment of portal hypertension and variceal bleeding.- 17 Management of ascites and spontaneous bacterial peritonitis.- SECTION VII: SEQUELAE OF CHRONIC HEPATITIS (PART 2).- 18 Advances in the pathogenesis and treatment of type 1 and type 2 hepatorenal syndrome.- 19 Hepatopulmonary syndrome.- 20 Hepatocellular carcinoma Index
